---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-264838"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2022-10-19T23:59:59+00:00"
generated_at: "2026-06-23T02:34:43.545557+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q3 GAAP EPS $6.68, adj. $7.53; revenue up 11.5%; raises FY2022 outlook

## Summary
- GAAP net income $6.68/share vs $6.79 adjusted; adjusted EPS $7.53, up 10.9% YoY.
- Operating revenue $39.6B (+11.5% YoY), driven by membership growth and premium rate increases.
- Medical membership 47.3M, up 2.2M YoY (+4.9%), with growth in Medicaid, commercial fee-based, and Medicare Advantage.
- FY2022 GAAP net income guidance raised to >$25.33/share; adjusted net income >$28.95/share.
- Q4 dividend declared $1.28/share, payable Dec 21, 2022 to holders of record Dec 5.

## SEC filing metadata
- accession: 0001193125-22-264838
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2022-10-19T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000119312522264838/0001193125-22-264838-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000119312522264838/d401070d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-264838
- JSON: https://secwatch.observer/filing/0001193125-22-264838.json
- Plain text: https://secwatch.observer/filing/0001193125-22-264838.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.